Advisory Committee to the Director (ACD), Centers for Disease Control and Prevention-National Biosurveillance Advisory Sbcommittee (NBAS), 12122 [2011-4994]
Download as PDF
<![CDATA[
12122
Federal Register / Vol. 76, No. 43 / Friday, March 4, 2011 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2011–4944 Filed 3–3–11; 8:45 am]
Dated: February 25, 2011.
Elaine L. Baker,
Director, Management Analysis and Services
Office Centers for Disease Control and
Prevention.
BILLING CODE 4163–18–P
[FR Doc. 2011–4994 Filed 3–3–11; 8:45 am]
[Document Identifier CMS–102 and CMS–
105, and CMS–10241]
Dated: February 25, 2011.
Thelma Sims,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
jlentini on DSKJ8SOYB1PROD with NOTICES
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following meeting of
aforementioned subcommittee:
Time and Date: 8:30 a.m.–11:30 a.m.,
March 21, 2011.
Place: Emory Conference Center Hotel,
1615 Clifton Road, NE., Atlanta, Georgia
30329, Telephone: (404) 712–6000.
Status: Open to the public, limited only by
the space available. The meeting room
accommodates approximately 75 people. The
public is welcome to participate during the
public comment periods. The public
comment period is tentatively scheduled for
11 a.m.–11:15 a.m.
Purpose: As a subcommittee to the CDC’s
Advisory Committee to the Director (ACD),
the NBAS will provide counsel to the CDC
and the Federal government through the ACD
regarding a broad range of human health
surveillance issues arising from the
development and implementation of a
roadmap for the human health component of
a national biosurveillance system.
Matters to be Discussed: Agenda items will
include the subcommittee’s discussion,
deliberation, and vote on the proposed report
for enhancing the nation’s biosurveillance
capability.
The agenda is subject to change as
priorities dictate.
Contact Person for More Information:
Pamela Diaz, M.D., Designated Federal
Officer, ACD, CDC—NBAS, 1600 Clifton
Road, NE., M/S E–97, Atlanta, Georgia 30333.
Telephone: (404) 498–0476. E-mail:
pdiaz@cdc.gov. For security reasons,
members of the public interested in attending
the meeting should contact Mark Byers,
Telephone: (404) 498–0481, E-mail:
mbyers@cdc.gov. The deadline for
notification of attendance is March 10, 2011.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
19:16 Mar 03, 2011
Jkt 223001
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
Centers for Medicare &
Medicaid Services
In compliance with the requirement
of section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995, the
Centers for Medicare & Medicaid
Services (CMS), Department of Health
and Human Services, is publishing the
following summary of proposed
collections for public comment.
Interested persons are invited to send
comments regarding this burden
estimate or any other aspect of this
collection of information, including any
of the following subjects: (1) The
necessity and utility of the proposed
information collection for the proper
performance of the Agency’s function;
(2) the accuracy of the estimated
burden; (3) ways to enhance the quality,
utility, and clarity of the information to
be collected; and (4) the use of
automated collection techniques or
other forms of information technology to
minimize the information collection
burden.
1. Type of Information Collection
Request: Extension without change of a
currently approved collection; Title of
Information Collection: Clinical
Laboratory Improvement Amendments
of 1988 (CLIA) Budget Workload
Reports and Supporting Regulations in
42 CFR 493.1–.2001; Use: The collected
information will be used by CMS to
determine the amount of Federal
reimbursement for surveys conducted.
Use of the information includes program
evaluation, audit, budget formulation
and budget approval. Form CMS–102 is
a multi-purpose form designed to
capture and record all budget and
expenditure data. Form CMS–105
captures the annual projected CLIA
workload that the State survey agency
will accomplish. It is also used by the
CMS regional office to approve the
annual projected CLIA workload. The
information is required as part of the
section 1864 agreement with the State;
Form Numbers: CMS–102 and CMS–105
(OMB#: 0938–0599); Frequency:
Quarterly; Affected Public: State, Local,
or Tribal Governments; Number of
Respondents: 50; Total Annual
Responses: 50; Total Annual Hours:
4,500. (For policy questions regarding
AGENCY:
Advisory Committee to the Director
(ACD), Centers for Disease Control and
Prevention—National Biosurveillance
Advisory Sbcommittee (NBAS)
VerDate Mar<15>2010
Centers for Medicare & Medicaid
Services
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): The
Association of Genetic Biomarkers and
Hereditary Hemochromatosis, DD11–
008, Initial Review
Correction: This notice was published
in the Federal Register on January 21,
2011, Volume 76, Number 14, Page
3908. The date for the aforementioned
meeting has been changed to the
following:
April 26, 2011 (Closed)
Contact Person for More Information:
Michael Dalmat, Dr.P.H., Scientific
Review Officer, CDC, National Center
for Chronic Disease Prevention and
Health Promotion, Office of the Director,
Extramural Research Program Office,
4770 Buford Highway, NE., Mailstop
K–92, Atlanta, Georgia 30341,
Telephone: (770) 488–6423, E-mail:
MED1@CDC.GOV.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
DATES:
Dated: February 25, 2011.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2011–4990 Filed 3–3–11; 8:45 am]
BILLING CODE 4163–18–P
PO 00000
Frm 00110
Fmt 4703
Sfmt 4703
E:\FR\FM\04MRN1.SGM
04MRN1
]]>Agencies
[Federal Register Volume 76, Number 43 (Friday, March 4, 2011)]
[Notices]
[Page 12122]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-4994]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Advisory Committee to the Director (ACD), Centers for Disease
Control and Prevention--National Biosurveillance Advisory Sbcommittee
(NBAS)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the following meeting of aforementioned
subcommittee:
Time and Date: 8:30 a.m.-11:30 a.m., March 21, 2011.
Place: Emory Conference Center Hotel, 1615 Clifton Road, NE.,
Atlanta, Georgia 30329, Telephone: (404) 712-6000.
Status: Open to the public, limited only by the space available.
The meeting room accommodates approximately 75 people. The public is
welcome to participate during the public comment periods. The public
comment period is tentatively scheduled for 11 a.m.-11:15 a.m.
Purpose: As a subcommittee to the CDC's Advisory Committee to
the Director (ACD), the NBAS will provide counsel to the CDC and the
Federal government through the ACD regarding a broad range of human
health surveillance issues arising from the development and
implementation of a roadmap for the human health component of a
national biosurveillance system.
Matters to be Discussed: Agenda items will include the
subcommittee's discussion, deliberation, and vote on the proposed
report for enhancing the nation's biosurveillance capability.
The agenda is subject to change as priorities dictate.
Contact Person for More Information: Pamela Diaz, M.D.,
Designated Federal Officer, ACD, CDC--NBAS, 1600 Clifton Road, NE.,
M/S E-97, Atlanta, Georgia 30333. Telephone: (404) 498-0476. E-mail:
pdiaz@cdc.gov. For security reasons, members of the public
interested in attending the meeting should contact Mark Byers,
Telephone: (404) 498-0481, E-mail: mbyers@cdc.gov. The deadline for
notification of attendance is March 10, 2011.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention
and the Agency for Toxic Substances and Disease Registry.
Dated: February 25, 2011.
Elaine L. Baker,
Director, Management Analysis and Services Office Centers for Disease
Control and Prevention.
[FR Doc. 2011-4994 Filed 3-3-11; 8:45 am]
BILLING CODE 4163-18-P
